A new drug that could save the US billions just got one step closer to an approval
A US Food and Drug Administration (FDA) advisory committee just gave a critical recommendation for a version of Humira, the blockbuster arthritis drug made by AbbVie that brought in $14 billion in sales in 2015. The panel voted unanimously in favor of…